The pivotal factors that are driving the Global Rat Model market include the wide adoption of personalized medicine, drug discovery & development. Global Rat Model Market is expected to grow significantly due to rise in incidence and prevalence rate of lifestyle-oriented diseases, growing personalized medicines and preference of rat models over mice and other animals. R&D exploration through rat models enables to bring new treatment and drugs for cardiovascular, stroke and other fatal diseases. Funding and grants from government and private players are also key factors that are motivating the global rat model market. However, stringent government regulations and FDA vigilance over precise control on the use of animals in laboratories, pressure from NGO’s and Animal welfare society, ethical laws and concerns over animal testing may affect the growth of Rat model market.
Rat models have considerable demand from developed and developing economies such as US, UK, Spain, China, India, and Korea. North America generates the highest revenues across the globe due to cohesive government policies, rising prevalence of CVD, stroke, hypertension, cancer and other heart-related diseases followed by Europe. North America has the highest healthcare spending and R&D investments followed by Europe. Untapped APAC region such as China, India, Japan, and Korea are the most emerging economies and expected to create a huge opportunity for Rat Model market. Improved healthcare spending, infrastructure, and favorable government policies are the key factors which are expected to drive the APAC market. The report includes a detailed market overview, market determinants, company profiling, competitive landscape, geographical analysis, strategic recommendations, key company analysis, key findings, analyst insights and predictive analysis of the market. The report also covers various factors that influence the market such as government regulations, drug and device laws and regulations, regulations on clinical trials, government policies and so forth.
The key players in global rat model market includes Biomedical Research Models, Inc., Braintree Scientific Inc., Charles River Laboratories, Inc., Covance, Inc., Envigo, Genoway S.A., Ozgene Pvt Ltd, SAGE Labs, Inc., The Jackson Laboratory, Transgenic, Inc., Transposagen Biopharmaceuticals, Inc., and Transviragen, Inc. Partnership, Collaboration, and R&D are the key strategies adopted by market players.
1. Global Rat Model Market Research and Forecast, By technology
2. Global Rat Model Market Research and Forecast, By type
3. Global Rat Model Market Research and Forecast, By therapeutics
4. Global Rat Model Market Research and Forecast, By product
5. Global Rat Model Market Research and Forecast, By end user
6. Global Rat Model Market Research and Forecast, By Geography
Research Methods and Tools
The study of rat model market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary sources include
- Financial reports of companies involved in the market
- Forward-looking statement of key rat model market players
- Authentic Public Databases
- Whitepapers, research-papers, and news blogs
- Company websites and their product catalog
The Report Covers:
- Comprehensive research methodology of Global Rat Model
- This report also includes a detailed and extensive market overview with key analyst insights.
- The exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Global Rat Model
- Insights about market determinants which are stimulating the Global Rat Model
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
Chapter 2. Market Overview and Insights
2.2. Analyst & Current Market Trends
2.2.1. Key Findings
18.104.22.168. United States
22.214.171.124. European Union
126.96.36.199. Rest of the World
Chapter 3. Market Determinant
3.1.1. Rise In Adoption of Personalized Medicines
3.1.2. Rapid Increase In Cvd, Cancer and Other Lifestyle-Oriented Diseases
3.1.3. Advancement and Growth In Bioinformatics
3.1.4. Variety of Rat Models Available That Provides Information For Human Diseases
3.1.5. Technological Advancement and Innovation To Boost Rat Model Market
3.2.1. Availability of Alternatives and Their Development
3.2.2. Stringent Government Regulation and Ethical Laws Are Still Concern For Global Rat Model Market
3.3.1. Emerging Market Such As Apac Region
3.3.2. Increase In the Investments From Key Players To Enter the Market
3.3.3. Research and Development On Rat Model
3.3.4. Increase In the Clinical Trials
Chapter 4. Market Segmentation
4.1. Global Rat Model Market by Technology
4.1.1. Micro Injection
4.1.2. Embryonic Stem Cell Injection
4.1.3. Nuclear Transferase Technology
4.2. Global Rat Model Market by Type
4.2.1. Inbred Rats
4.2.2. Knockout/Genetically Engineered Rats
4.2.3. Outbred Rats
4.2.4. Hybrid/Congenic Rats
4.2.5. Conditioned/Surgically Modified Rats
4.2.6. Immunodeficient Rats
4.3. Global Rat Model Market by Therapeutics
4.3.3. Immunology and Inflammation
4.4. Global Rat Model Market by Services
4.4.1. Genetic Testing
4.4.2. Model In Licensing
4.4.6. Genetic Testing
4.5. Global Rat Model Market by Product
4.6. Global Rat Model Market by End User
4.6.1. Pharmaceutical and Biotechnology Companies
4.6.2. Academic and Research Institutions
4.6.3. Contract Research Organisation(Cro)
Chapter 5. Competitive Landscape
5.1. Key Strategies
5.2. Key Company Analysis
Chapter 6. Regional Analysis
6.1. North America
6.1.1. United States
6.2.1. United Kingdom
6.2.6. Rest of Europe
6.3. Asia Pacific
6.3.4. Rest of Asia Pacific
6.4. Rest of the World
Chapter 7. Company Profiles
7.1. Aragen Bioscience, Inc.
7.2. Biomedical Research Models, Inc.
7.3. Charles River Laboratories
7.4. Braintree Scientific, Inc.
7.5. Covance Inc.
7.6. Creative Animodel
7.7. Davinci Biomedical Research Products, Inc.
7.9. Genoway S.A.
7.10. Hilltop Lab Animals, Inc.
7.11. Hylasco Biotechnology Pvt. Ltd.
7.12. Ingenious Targeting Laboratory
7.13. Janvier Labs
7.14. Ozgene Pty Ltd.
7.15. Scireq Scientific Respiratory Equipment Inc.
7.16. Taconic Biosciences, Inc.
7.17. The Jackson Laboratory
7.18. Transgenic Inc.
7.19. Transposagen Biopharmaceuticals, Inc.
7.20. Transviragen, Inc.
- Aragen Bioscience, Inc.
- Biomedical Research Models, Inc.
- Charles River Laboratories
- Braintree Scientific, Inc.
- Covance Inc.
- Creative Animodel
- Davinci Biomedical Research Products, Inc.
- Genoway S.A.
- Hilltop Lab Animals, Inc.
- Hylasco Biotechnology Pvt. Ltd.
- Ingenious Targeting Laboratory
- Janvier Labs
- Ozgene Pty Ltd.
- Scireq Scientific Respiratory Equipment Inc.
- Taconic Biosciences, Inc.
- The Jackson Laboratory
- Transgenic Inc.
- Transposagen Biopharmaceuticals, Inc.
- Transviragen, Inc.